chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to the ER  due to cough and fatigue she experienced over the past 5 days  without shortness of breath. The patient was on room air.  Sodium was 129.  She was admitted to the hospital.  She did well during her stay. She refused monoclonal antibodies.  Discussed risks and benefits with her. She verbalized understanding.  We discontinued her hydrochlorothiazide because of hyponatremia.  Sodium improved to 134.  Procalcitonin was 0.1.  BNP 104. Blood culture was negative.  The patient continued to be on room air.  Two- dimensional echo showed EF 60%, diastolic dysfunction.  Chest x-ray showed possible left lower lobe infiltrate.  Clinically, unlikely pneumonia, probably secondary to COVID-19.  The patient did well, and she was discharged in stable Condition with covid kit The patient received Zithromax and Rocephin during her stay.
Narrative: Covid +, Pfizer x 2, Moderna x 1, SOB, not acute, chronic, sign COPD, S&S home
PFizer vaccine was administered after being discovered that the vaccine was in the freezer for 11 days longer than the two week standard time.
On 09/03/2022, I accidently administered a Pfizer dose which expired 08/31/2022.  Patient was contacted and no reaction was found.
Leg swelled and turned red within 12 hours of vaccine. Low grade fever, decreased eating, increased sleep and fussiness 18 hours after vaccines.
Patient presented to emergency room on 12/16/2021 due to syncope and fatigue. She was found to be hypotensive. She was found to be COVID-19 positive during screening for admission. She remained asymptomatic for COVID-19 during admission and required no treatment. Patient was discharged to her living facility on 12/20/2021.
Dizziness,  rash over forehead, face & neck.  No respiratory distress, sob. Patient received vaccine & experienced ade during employee flu clinic Employee was sent to occupational health & examined by md.  Diphenhydramine 25mg po was administered. Patient recovered
5 hours after injection sore arm; 10pm that same night could not move arm.  Saw PCP after Christmas who ordered MRI.  Showed inflammation and patient started physical therapy.  On 2/18/16, patient saw an orthopedic surgeon who evaluated patient and stated no tares, but extreme inflammation of upper arm/rotator cuff area most likely due to flu shot given too high in arm.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster) single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Violent diarrhea & throwing up for both shots, much worse and longer on 2nd shot, then returning for one day here and there. Enlarged spleen found by ultrasound after complaining of side pain. Only 2 menses in 19 months now gets heavy clots every 3 weeks following first Gardasil vaccine on 10/25/2013. Liver is enlarged as well as liver studies showing liver is overworked...currently waiting on studies. Vitamin D deficient. Constipated.
Immunization given on 02/10/2023 at pharmacy when reviewing pt shot record for 2nd dose follow up. Dr office reported to clinic on 2/14/2023 they had administered Shingrix shot to pt on 02/05/2023
Developed fever and rash. Unknown temperature due to child not cooperating to have checked. Vomiting a couple of times. Rash to entire body that is non-raised and appears bright red. Family doctor checked child and feels it may be normal reaction from MMR according to mom. Doctor felt child vomited from high fever. Mom states rash getting better--not worse. Child appears to feel beter according to mother.
Patient called the to report adverse effects following vaccination with Moderna, especially following her second dose. )Her first dose was given on 1/16/21, and she immediately experienced nausea. Pt stated in was administered in the L arm, but ALERT IIS stated R arm.) After the second dose, she reported immediate nausea, milder than after the first vaccine, and then  "breathing trouble"--a "squeezing heart" sensation that began about 10 minutes after vaccination and lasted for close to one hour. She also immediately began to have pain in her Left arm (the 2nd vaccine dose was administered in her Right arm). This pain has continued to grow and intensify; she called in on 2/24/21 and on 2/25/21 reported that it is even worse. She is planning to go to an urgent care but finds it difficult as she has 5 children at home.
around 24 hours after receiving the second dose my wife became  ill with Diarrhea which progressed to severe Diarrhea ever few minutes for hours at a time. This became progressively worse and since we are uninsured we trusted it would go away after a few days.   After 7 days ( the maximum duration we saw on the internet for this side effect)  things were not better and we visited the ER Doctor  noted  my wife was dehydrated  and he ran blood tests  Plus gave her 1 liter of Sodium Chloride, Ibuprofen and Simethicone and Aceminphen.   He noted there was not much else he could do and we needed to be patient for things to get better  plus gave advice on food ( which we already tried)    AS of right now  Sunday night  7/11/2021  my wife still has severe Diarrhea , no real improvement over the last 5  days.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/15/21ModernaLot#01320A 2nd dose:02/11/21 Moderna Lot# 013220A Diagnosed covid positive:07/28/21 Symptom onset:07/25/21 Exposure:unknown Symptoms:fever, SOB,Head aches, chills,cough chills,loss of smell/taste
24 hrs after injection outer aspect of (R) arm from deltoid to just above elbow red, warm and swollen
Pain, limited mobility in arm. Went to urgent care. Was told not to get the second MMR shot.
I have a fever; my body hurts a lot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I have a fever) and MYALGIA (my body hurts a lot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have a fever) and MYALGIA (my body hurts a lot). At the time of the report, PYREXIA (I have a fever) and MYALGIA (my body hurts a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
DIZZINESS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of dizziness was not reported. This report was non-serious.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) by a physician, for routine adult health maintenance and the intended purpose for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. The patient was diagnosed with shingles after being inoculated with the ZOSTAVAX and suffered serious physical, emotional, and economic damages as a result of his shingles and associated injuries. On an unknown date in 2015, the patient was treated by the physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
gave an adolescent a booster dose of the Moderna Covid-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave an adolescent a booster dose of the Moderna Covid-19 Vaccine) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer and Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave an adolescent a booster dose of the Moderna Covid-19 Vaccine). On 09-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave an adolescent a booster dose of the Moderna Covid-19 Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The patient received 2 doses of Pfizer as their primary series, patient did not have the administration dates, but stated that booster dose was taken after more than 6 months since their second dose.
COVID vaccine breakthrough case. Pfizer EN6200 on 3/27/21, Pfizer EW0162 on 4/17/21, and boosted with Pfizer FH8020 on 11/02/21.
Shivering; Could not get warm; Felt like hit by a truck all day today/ still feeling awful; Fever; Stiff joints; Injection site swelled up like a golf ball; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 40-years-old female patient received bnt162b2 (BNT162B2),(Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) dose 2 SINGLE via an unspecified route of administration on 15Apr2021 for covid-19 immunisation.The patient medical history was not reported. The patient's concomitant medications were not reported. The patient Historical Vaccine was (BNT162B2Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) as a dose 1 single via an unspecified route of administration on an unknown date. The patient on 16Apr2021 wakes up at 2 am shivering, could not get warm, felt like hit by a truck all day today, fever, stiff joints. injection site swelled up like a golf ball, been over 24 hours and still feeling awful. The outcome of all events was unknown.
A pharmacist reported that several employees received Flu Shield and subsequently developed the flu. The reporter stated that the vaccine may have been left out.
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning a seven-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 20-Nov-2011. The patient received the FLUMIST between 23-Nov-2011. The patient received a repeat dose. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. The reporter stated that the patient did not experience any late occurring adverse events.
2 hive like areas about 3 inches below site of injection; 2 hive like areas about 3 inches below site of injection that is painful to touch; blister type rash on torso; This case was reported by a other health professional via interactive digital media and described the occurrence of hives in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th November 2020, the patient received the 1st dose of Shingrix. On 2nd December 2020, 3 days after receiving Shingrix, the patient experienced hives, pain and blistery rash. On an unknown date, the outcome of the hives, pain and blistery rash were unknown.   It was unknown if the reporter considered the hives, pain and blistery rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but captured as adult as per vaccine indication. The patient received 1st dose of Shingrix 3 days ago from the date of reporting. At the time of reporting, the patient had 2 hive like areas about 3 inches below site of injection that was painful to touch.  The patient also had a blister type rash on torso.  The reporter asked, should he or she need to be concerned about being contagious in any way to his or her patients
School nurse called our office to report pt is c/o not being able to move his arm very well and having a hard time writing. Injection site is red and has a small bump. No fever noted. Mom is aware of reaction and will bring pt in if needed but right now is giving pt Ibuprofen for pain/swelling. At time of this report pt has not come into the office for further evaluation.
erythema of thigh from knee-to hip; no fever, no irritability; erythema resolved in 6 days;
RIGHT BUNDLE BLOCK; HEART SWELLING; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other company concerned a 61 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy, and other pre-existing medical conditions included: The patient was not pregnant at the time of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine and not any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 since the vaccination. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, 1 total administered on 06-MAR-2021 09:00 am to left arm for covid-19 prophylaxis. Age at time of vaccination was 60 years. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). On an unspecified date in JUL-2021, Laboratory data included: EKG (Electrocardiogram) was normal. The patient also received non-company suspect vaccine Pfizer Biontech Covid-19 Vaccine (tozinameran), (Dose number in series 2), (batch number: 301458A expiry: UNKNOWN, form of admin, route of admin were not reported) dose was not reported, administered on 22-OCT-2021 15:00 pm to left arm for covid-19 prophylaxis which was a revaccination with different covid-19 vaccine (Dose number in series 2). No concomitant medications were reported. On an unspecified date in SEP-2022, laboratory data included EKG which showed right bundle block due to heart swelling (Dose number in series 2). On an unspecified date in SEP-2022, echocardiogram showed no signs of heart problems or disease.  The patient was concerned to have heart swelling after Pfizer MRNA booster which caused right bundle block. The patient had no other health changes between the Pfizer booster and the latest EKG (SEP-2022). The action taken with covid-19 vaccine ad26.cov2.s, and tozinameran was not applicable. The patient recovered with sequelae from right bundle block, and heart swelling, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.; Sender's Comments: V0- Medical assessment comment is not required as per standard procedure as case was assessed as non-serious.
I had a fever, and I was very nauseous, lack of appetite, and I felt extremely dizzy. I developed chills, and a sore throat the next day. On the second day of my symptoms I took an at home Covid test that came back positive. My symptoms lasted for about 1 week.
Sore skin; Arm is sore and hurting terribly.; Bad chills; Bad headache; Sore muscles; Fever running pretty hot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN OF SKIN (Sore skin), PAIN IN EXTREMITY (Arm is sore and hurting terribly.), CHILLS (Bad chills), HEADACHE (Bad headache) and MYALGIA (Sore muscles) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN OF SKIN (Sore skin), PAIN IN EXTREMITY (Arm is sore and hurting terribly.), CHILLS (Bad chills), HEADACHE (Bad headache), MYALGIA (Sore muscles) and PYREXIA (Fever running pretty hot). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN OF SKIN (Sore skin), PAIN IN EXTREMITY (Arm is sore and hurting terribly.), CHILLS (Bad chills), HEADACHE (Bad headache), MYALGIA (Sore muscles) and PYREXIA (Fever running pretty hot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 103.5 (High) 103.5 F and 102 (High) 102 F.         Concomitant product use was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments
Client states immediately after vaccine administration he noticed a strange taste in his mouth. At home the evening of 09/22/2011 states onset of dizziness and general malaise. Morning of 09/23/2011 complaint of dizziness and "cold sweats". No reported fever, nausea, or vomiting.
Nausea immediately after injection, joint and muscle pain, sharp back spasms shortly , site soreness, mild headache
PATIENT STARTED EXPERIENCING SYMPTOMS AT 1930 THE SAME DAY VACCINE WAS ADMINISTERED. SYMPTOMS INCLUDED BLURRY VISION, OCULAR HYPEREMIA, SEVERE HEADACHE, REDNESS AND HEAD AT INJECTION SITE, MALAISE, FEELING OF COLD, DYSPNEA. CLIENT WENT TO BED AND FELT BETTER THE NEXT DAY. CLIENT CONTINUES TO FEEL A LITTLE TIRED BUT BETTER.
'My' period cycle started 10 days early and it is heavier than usual; 'My' period cycle started 10 days early and it is heavier than usual; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at the age of 33-years-old as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021, the patient's period cycle started 10 days early and it was heavier than usual. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period cycle started 10 days early and it was heavier than usual was resolving at the time of the report.   No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
15 persons received Pfizer vaccine from vials that has been reconstituted with 1.3 mL instead of 1.8 mL.; received Pfizer vaccine from vials that has been reconstituted with 1.3 mL instead of 1.8 mL.; significant body aches.; nausea; vomiting; diarrhea; This is a spontaneous report from a contactable physician. This physician reported similar events for fifteen patients. This is 8th of fifteen reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that during a second clinic 15 persons received Pfizer vaccine from vials that has been reconstituted with 1.3 mL instead of 1.8 ml. They reported significant body aches. Many had GI symptoms (nausea, vomiting and diarrhea). The seriousness of the events was reported as non-serious. The outcome of all the events was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021188834 Same reporter/drug/event, different patient.
PATIENT RECEIVED PFIZER 1ST DOSE ON 12/23/2020 AND DIDNT COME BACK AT 3WEEK APPOINTMENT AND THEN CAME BACK AT 4TH WEEK AND IN ERROR RECEIVED MODERNA 2ND DOSE
Sore shoulder and arm lasting four weeks,plus hurts to lift or sleep on arm, heat, aspercreme not helping, aches most of the time
Pfizer-BioNTech COVID-19 Vaccine EUA Swollen lymph nodes (under arm-size of a grapefruit) 3 days rash (2nd day) tiredness (3 days) nausea (3 days) body aches (3 days) injection site redness/swelling (one day)
Within 2 hours, morbilliform rash appeared on this infants chest and abdomen lasting 48 hours. No other sickness.
Client came in for a travel vaccines.  Was given oral Typhoid Fever on 2/17/04. He took his first pill on 2/18/04 at 7 am on an empty stomach. At 7:30 am, he started to have a headache. Took some Advil and it started to get worse. At 8 am, he ate something and no relief of his headache. At 8:30, drank some coffee thinking the caffine would help, but it didn't.  Took some more Advil.  Had some nausea around 1-1:30 pm.  Finally headache started to subside around 3:30-4 pm. By the next day, he stated he was about 90% better.
Three days after receiving the vaccine the patient started having nonspecific constitutional symptoms. A few days after that he developed additional symptoms of nausea, vomiting, abdominal pain, and dark urine. After several days of worsening symptoms he sought care and was found to have acute hepatitis
Redness, bumps and bruise at/around injection site. Headache, fatigue, nausea, cough, stiffness.